The comparison of expression profiling data of PRELP−/− retina and human cancers has revealed that influenced mechanisms and genes in PRELP−/− retina are highly conserved with cancer progression mechanisms in other cancers (Figure 4E), indicating that the PRELP downregulation in human RB contributes to the progression through regulation of the pathways regulated by PRELP. The gene discussed is RB1; the disease is cancer.